top of page

Eksamples 2000-


Arendt-Nielsen, L., Nielsen, T. A., & Gazerani, P. Translational pain biomarkers in the early development of new neurotherapeutics for pain management. Expert Review of Neurotherapeutics, 2014, 14(3), 241-254.

Hayes, A. G., Arendt-Nielsen, L., & Tate, S. Multiple mechanisms have been tested in pain: how can we improve the chances of success?. Current Opinion in Pharmacology, 2014 14(1), 11-17.

Arendt-Nielsen, Lars; Gazerani, Parisa. Human pain models in analgesic drug development. In: Pain Models: Translational Relevance and Applications. Eds. Hermann O. Handwerker; Lars Arendt-Nielsen. International Association for the Study of Pain/IASP Press, 2013, 281-297

Arendt-Nielsen, L., & Curatolo, M. Mechanistic, translational, quantitative pain assessment tools in profiling of pain patients and for development of new analgesic compounds. Scandinavian Journal of Pain, 2013; 4(4), 226-230.

Arendt-Nielsen, L., & Hoeck, H. C. Optimizing the early phase development of new analgesics by human pain biomarkers. Expert Review of Neurotherapeutics, 2011, 11(11), 1631-1651.

Staahl, C., Upton, R., Foster, D. J., Christrup, L. L., Kristensen, K., Hansen, S. H., Arendt-Nielsen, L., & Drewes, A. M. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model. Journal of Clinical Pharmacology, 2008, 48(5), 619-631.

Arendt-Nielsen, L., Curatolo, M., & Drewes, A. Human experimental pain models in drug development: translational pain research. Current Opinion in Investigational Drugs, 2007, 8(1), 41-53.

Staahl, C., Reddy, H., Andersen, S. D., Arendt-Nielsen, L., & Drewes, A. M. Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics. Basic & Clinical Pharmacology & Toxicology, 2006, 98(2), 201-211

bottom of page